10.1016/j.bcp.2021.114578 Biochem
Clinical and member reports include: Studies outside Noom, including a 2,700-person Denmark trial, suggest users who stayed at microdose levels saw 16% body weight loss over 64 weeks, with minimized side effects (fatigue, GI upset) and improved cholesterol, markers of inflammation, and overall health. One user lost 25 pounds through Noom GLP 1 Cost support, reporting, Taking a GLP-1 significantly reduced my appetite, which meant I had to be intentional about getting enough nutrients
Technically yes
You can reach our U.S.-based support team via live chat, email, or phone
Not hype
Semaglutide works through GLP-1 alone, and tirzepatide combines GLP-1 with GIP, but neither touches glucagon